ReviewSensors (Basel, Switzerland)2019
Biosensors for Epilepsy Management: State-of-Art and Future Aspects.
Review in Sensors (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 50 citations in OpenAlex.
- Smart bio-implants for seizure prediction in tuberous sclerosis complex.Annals of medicine and surgery (2012) · 2026Article
- DNA-Based Near-Infrared Voltage Sensors.ACS sensors · 2023Article
- Wearable Electromyography Classification of Epileptic Seizures: A Feasibility Study.Bioengineering (Basel, Switzerland) · 2023Article
- Antibacterial and antiviral high-performance nanosystems to mitigate new SARS-CoV-2 variants of concern.Current opinion in biomedical engineering · 2022Review
- Sensing beyond Senses: An Overview of Outstanding Strides in Architecting Nanopolymer-Enabled Sensors for Biomedical Applications.Polymers · 2022Review
- A Study on Seizure Detection of EEG Signals Represented in 2D.Sensors (Basel, Switzerland) · 2021Article
- Smart diagnostics devices through artificial intelligence and mechanobiological approaches.3 Biotech · 2020Review
- How technology is driving the landscape of epilepsy surgery.Epilepsia · 2020Review
- Erratum: Tiwari, S., et al. Biosensors for Epilepsy Management: State-of-Art and Future Aspects.Sensors (Basel, Switzerland) · 2019Article
- Phyllathin From Phyllanthus Amarus Ameliorates Epileptic Convulsion and Kindling Associated Post-Ictal Depression in Mice via Inhibition of NF-κB/TLR-4 Pathway.Dose-response : a publication of International Hormesis SocietyArticle
- Wearable sensors and features for diagnosis of neurodegenerative diseases: A systematic review.Digital healthReview
Corrections and comments
- Erratum issued
Authors and funding
6 authors at 5 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epilepsy is a serious neurological disorder which affects every aspect of patients' life, including added socio-economic burden. Unfortunately, only a few suppressive medicines are available, and a complete cure for the disease has not been found yet. Excluding the effectiveness of available therapies, the timely detection and monitoring of epilepsy are of utmost priority for early remediation and prevention. Inability to detect underlying epileptic signatures at early stage causes serious damage to the central nervous system (CNS) and irreversible detrimental variations in the organ system. Therefore, development of a multi-task solving novel smart biosensing systems is urgently required. The present review highlights advancements in state-of-art biosensing technology investigated for epilepsy diseases diagnostics and progression monitoring or both together. State of art epilepsy biosensors are composed of nano-enabled smart sensing platform integrated with micro/electronics and display. These diagnostics systems provide bio-information needed to understand disease progression and therapy optimization timely. The associated challenges related to the development of an efficient epilepsy biosensor and vision considering future prospects are also discussed in this report. This review will serve as a guide platform to scholars for understanding and planning of future research aiming to develop a smart bio-sensing system to detect and monitor epilepsy for point-of-care (PoC) applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.